Compare
Pulmonx Corp vs Kestra Medical Technologies, Ltd. vs Delcath Systems, Inc. vs Iradimed Corp
| Latest fiscal year | Pulmonx Corp LUNG | Kestra Medical Technologies, Ltd. KMTS | Delcath Systems, Inc. DCTH | Iradimed Corp IRMD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-04-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $90.50M | $95.13M | $85.23M | $83.81M |
| Revenue growth (YoY) | +8.0% | +59.0% | +129.1% | +14.4% |
| Gross margin | 74.2% | 51.4% | 86.2% | 76.7% |
| Operating margin | -59.3% | -141.6% | 0.8% | 31.2% |
| Net margin | -59.7% | -138.4% | 3.2% | 26.8% |
| Net income | -$54.00M | -$131.61M | $2.70M | $22.48M |
| EPS (Diluted) | -$1.33 | -$2.43 | $0.07 | $1.75 |
| Operating cash flow | -$32.38M | -$81.70M | $22.52M | $24.95M |
| Free cash flow | -$32.83M | -$116.59M | $20.97M | $17.18M |
| Cash & equivalents | $69.75M | $99.71M | $43.45M | $51.16M |
| Total assets | $129.29M | $358.46M | $123.63M | $108.78M |
| Total liabilities | $75.17M | $98.81M | $12.41M | $14.16M |
| Shareholders' equity | $54.12M | $259.66M | $111.22M | $94.62M |
| Return on year-end equity | -99.8% | -50.7% | 2.4% | 23.8% |
| Shares outstanding | 41.67M | 58.38M | 34.69M | 12.78M |
Revenue, most recent five fiscal years
| Fiscal year | Pulmonx Corp | Kestra Medical Technologies, Ltd. | Delcath Systems, Inc. | Iradimed Corp |
|---|---|---|---|---|
| Latest | $90.50M Ended 2025-12-31 | $95.13M Ended 2026-04-30 | $85.23M Ended 2025-12-31 | $83.81M Ended 2025-12-31 |
| 1 year earlier | $83.79M Ended 2024-12-31 | $59.81M Ended 2025-04-30 | $37.20M Ended 2024-12-31 | $73.24M Ended 2024-12-31 |
| 2 years earlier | $68.67M Ended 2023-12-31 | $27.81M Ended 2024-04-30 | $2.06M Ended 2023-12-31 | $65.56M Ended 2023-12-31 |
| 3 years earlier | $53.66M Ended 2022-12-31 | n/a | $2.72M Ended 2022-12-31 | $53.30M Ended 2022-12-31 |
| 4 years earlier | $48.42M Ended 2021-12-31 | n/a | $3.56M Ended 2021-12-31 | $41.81M Ended 2021-12-31 |